Pharmafile Logo
Pharmafocus logo
Advanced Search
Dr Steve Yang

Double blow to Pfizer’s emerging markets strategy

December 10, 2010
Business Services, Sales and Marketing David Simmons, Ian Read, Jean-Michel Halfon, Jeffrey Kindler, Pfizer, Steve Yang, emerging pharma markets, recruitment

Pfizer has lost two senior executives with key roles in its emerging markets strategy. The departure of the company’s head …

News

Hormone therapy drugs ‘increase heart disease risk’

December 10, 2010
Research and Development AstraZeneca, Hormone therapy, Novartis, Pfizer, aromatase inhibitors, breast cancer, tamoxifen

Three aromatase inhibitors could increase the risk of heart disease in postmenopausal women with breast cancer, according to new data. …

News

Elan names Robert Ingram as new chairman

December 10, 2010
Research and Development, Sales and Marketing Elan, appointment, research and development, sales and marketing

Elan has appointed former Glaxo Wellcome chief executive Robert Ingram as its chairman-designate. Ingram led Glaxo between 1997 and 2000 …

Appointment

Valuing medicines and NHS reform – the ABPI view

December 10, 2010
Sales and Marketing ABPI, NHS reforms, Paul Catchpole, market access, value-based pricing

For those concerned with improving the value for money of medicines to the UK’s health service, the government’s White Paper …

Feature

Boehringer puts afatinib head-to-head with Herceptin

December 10, 2010
Research and Development BIBW 2992, Boehringer Ingelheim, Herceptin, Roche, Tovok, afatinib, breast cancer

Boehringer Ingelheim has set up a showdown between one of its pipeline oncology products and Roche’s Herceptin. It has started …

News

SHL Establishes New Facility in the USA for Final Assembly and Packaging of Auto-Injectors

December 10, 2010
Manufacturing and Production auto injector, autoinjector, final assembly, packaging, shl

SHL, a leading manufacturer of drug delivery devices, will further expand operations in the USA with the establishment of SHL …

News
Press release

Roche highlights R&D promise after setbacks

December 9, 2010
Research and Development MS, Roche, oncology, personalised medicine, schizophrenia

Roche has presented its pipeline to shareholders to boost confidence that it can sustain the spectacular growth of recent years. …

News
Andrew Lansley

First GP consortia named

December 9, 2010
Sales and Marketing Lansley, NHS, consortia, reforms

The first consortia of GPs who will spearhead England’s healthcare reforms have been unveiled. A total of 52 consortia from …

News
Blog footer

Digital Pharma: AZ launches its first UK iPhone app

December 8, 2010
Medical Communications Apple, AstraZeneca, Digital Pharma blog, apps, ipad, iphone

AstraZeneca has launched an iPhone app to provide UK healthcare professionals with information on genetic tests for lung cancer. The …

News

GSK acquires China’s Nanjing MeiRui Pharma for $70m

December 8, 2010
Manufacturing and Production, Sales and Marketing China, GSK, GlaxoSmithKline, Nanjing MeiRui Pharma, Pagoda Pharmaceuticals, SheNiTing

GlaxoSmithKline has continued its expansion into China with the $70 million acquisition of a local firm. Nanjing MeiRui Pharma Co’s …

News

William Vickery joins Hybrigenics

December 8, 2010
Research and Development Hybrigenics, William Vickery, appointment, research and development

Paris-based biopharmaceutical company Hybrigenics has appointed William Vickery to the newly-created position of head of corporate and business development. He …

Appointment

Astellas signs stem cell partnership in liver disease

December 8, 2010
Research and Development Astellas, Cytori, Stem cells, liver disease, regenerative medicine

Astellas has teamed up with Cytori Therapeutics to develop a range of new stem cell treatments for liver disease and …

News

Out-of-hour procedures for clinical trials

December 8, 2010
Research and Development GCP, Good Clinical Practice, Guy’s and St Thomas’ NHS Foundation Trust, Katherine Kennedy, clinical trials, trial safety

When a clinical trial subject is involved in a medical emergency, the hospital team need rapid access to information about …

Feature
Avastin packs

NICE no for Avastin in breast cancer

December 8, 2010
Sales and Marketing NICE, Roche, avastin, bevacizumab, breast cancer, health technology assessment, hta

NICE has refused to back Roche’s Avastin for use in breast cancer patients citing the blockbuster drug’s high cost and …

News

Contract research news in brief

December 8, 2010
Research and Development Cell Trends, Laboratory Corporation of America, PPD, Parexel, Patheon, Quintiles, Texcell, Unithink, contract research, contract research organisations

Our round-up of recent development in the contract research sector includes updates from Patheon, Parexel, PPD, Quintiles, Unithink, Texcell and …

News

WPP launches Healix Digital Health

December 7, 2010
Medical Communications Grey Healthcare, VML, WPP, digital marketing, digital marketing agency

A new digital healthcare agency, Healix Digital Health, has been launched by two companies within the WPP group. Grey Healthcare …

News

Trial hitch for Pfizer’s leukaemia drug submission plans

December 7, 2010
Research and Development, Sales and Marketing CML, Gleevec, Glivec, Pfizer, bosutinib, chronic myeloid leukaemia

Pfizer is pressing ahead with plans to submit bosutinib for European approval despite the chronic myeloid leukaemia drug missing its …

News

WikiLeaks defends decision to publish critical facilities list

December 7, 2010
Manufacturing and Production WikiLeaks, pharma manufacturing, security

Pharmaceutical facilities have featured prominently in in the latest batch of secret US embassy cables made public by WikiLeaks. The …

News

Takeda and Baxter make pandemic flu vaccine plans for Japan

December 7, 2010
Manufacturing and Production Takeda, baxter, pharma manufacturing, vaccine manufacturing, vaccines

Takeda has made another move into the vaccines sector with the expansion of a deal with Baxter International for the …

News

AZ’s Brilique approved in Europe

December 7, 2010
Sales and Marketing AZ, AstraZeneca, Brilique, Plavix, acute coronary syndromes, antiplatelet, atherothrombotic events, ticagrelor

European regulator have approved AstraZeneca’s oral antiplatelet Brilique (ticagrelor tablets). Brilique can now be used for the prevention of atherothrombotic …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026